Results 91 to 100 of about 436,361 (230)
Tolerated or Celebrated? Black Men in Doctoral Counselor Education Programs
Counselor Education and Supervision, EarlyView.ABSTRACT Black students face more difficulties when it comes to gaining doctoral degrees compared to other races. However, not enough is known about Black men in doctoral counselor education (CE) programs. Using interpretive phenomenological analysis and guided by Black Critical Theory, we explored the lived experiences of 10 Black men in doctoral CE ...
Demetrius Cofield +2 more
wiley +1 more source
Correcting Errors in the Adsorbed Intermediates of CO2 Electroreduction
Carbon Energy, EarlyView.Flying over Jacob's ladder of density functional approximations: chemical accuracy in the DFT‐based modeling of CO2 reduction electrocatalysis can be approached with our simple semiempirical method to deconvolute and correct gas‐phase errors and adsorbed‐phase errors.
Ricardo Urrego‐Ortiz +5 more
wiley +1 more source
LZTS2 Negatively Regulates Centrosomal CEP135 Levels and Microtubule Nucleation
Cytoskeleton, EarlyView.ABSTRACT The microtubule cytoskeleton is a fundamental functional component of the cell. In vertebrate proliferating cells, centrosomes are the primary microtubule organizing center (MTOC), and their dysregulation has been linked to genomic instability and cancer.
Catarina Peneda +4 more
wiley +1 more source
Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
Clinical Pharmacology &Therapeutics, EarlyView.Optimized dosing precision of antibody–drug conjugates (ADCs) remains challenging due to narrow therapeutic indices, efficacious doses near the maximum tolerated dose, and substantial interindividual variability in exposure. Body size‐based dosing can reduce exposure variability when the allometric scaling exponent for clearance α = 1 but may over‐ or ...
Andrew B. SyBing, Diane D. Wang
wiley +1 more source
Population Pharmacokinetics of Clesrovimab in Preterm and Full‐Term Infants
Clinical Pharmacology &Therapeutics, EarlyView.Clesrovimab is a half‐life extended monoclonal antibody targeting the respiratory syncytial virus fusion protein. Three studies (phase Ib/IIa [MK‐1654‐002], phase IIb/III [CLEVER], and phase III [SMART]) were conducted to evaluate the efficacy, safety, and pharmacokinetics (PK) of clesrovimab in infants.
Ziheng Hu +8 more
wiley +1 more source
MAD MEN: Análisis de conductas machistas en Mad Men
, 2014 Grado en Publicidad y Relaciones ...
openaire +1 more source
Conflict Resolution Quarterly, EarlyView.ABSTRACT Environmental conflicts are increasing as is interest in ways they can be managed. However, evaluations of Environmental Conflict Resolution (ECR) processes based on direct observation remain scarce, despite ECR existing for over half a century.
Callum Leavey‐Wilson +2 more
wiley +1 more source
Dr. Leena Krogerus: A Grand Old Lady of the Finnish Cytopathology and My Cytopathology Mum
Diagnostic Cytopathology, EarlyView.ABSTRACT The communication introduces former President of the Finnish Society of Clinical Cytology and organizer of the European Congress of Cytology in Rovaniemi, Dr. Leena Krogerus. She played an important role in the formation of my cytopathology career as she led my path in cytopathology education, research, and leadership.
Ivana Kholová
wiley +1 more source